Dr. Park has developed over 30 years of working experience in therapeutics development from early target discovery through late stage drug development in both academia and industry. Previously, he served as an adjunct Professor of College of Veterinary Medicine at Jeju National University with over 35 published research articles. Before joining ILIAS Biologics, he worked for big pharmaceuticals including GDFI Inc., SK Biopharmaceuticals, Jeil Pharmaceuticals as a Project leader and Executive Director. Now, as the head of R&D center of ILIAS Biologics, Dr. Park is leading company’s efforts for innovative therapeutics development with patented exosome-based drug delivery platform.
Dr. Park earned his Ph.D. in Neuropharmacology from Seoul National University, College of Medicine.